Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA
{{output}}
Background: Inhibitors of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in NAD+ biosynthesis from nicotinamide, exhibit anticancer effects in preclinical models. However, continuous exposure to NAMPT in... ...
